Monoclonal Antibody Therapy of T Cell Lymphoma: Single Agent Trials of Anti-CD2 (Siplizumab) and Anti-CD4 (Humax-CD4). Hematol Meeting Rep 2009, 3 (1). https://doi.org/10.4081/hmr.v3i1.532.